Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189)
Hong Kong · Delayed Price · Currency is HKD 0.3100
0.00 (0.00%)
At close: Feb 13, 2026
HKG:8189 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -30.11 | -27.8 | -20.16 | -27.45 | -42.26 | -48 |
Depreciation & Amortization | 9.13 | 9.13 | 11.63 | 15.05 | 9.51 | 7.1 |
Other Amortization | - | - | - | 0.34 | - | - |
Loss (Gain) From Sale of Assets | 0.28 | 0.28 | 0.2 | 0.05 | -0.15 | -0.24 |
Asset Writedown & Restructuring Costs | 7.16 | 7.16 | - | - | 22.26 | 9.55 |
Loss (Gain) From Sale of Investments | - | - | 0.94 | -5.96 | -2.34 | 1.71 |
Loss (Gain) on Equity Investments | - | - | - | - | -1 | 1.94 |
Provision & Write-off of Bad Debts | 9.99 | 9.99 | 9.48 | 4.89 | 11.74 | 20.11 |
Other Operating Activities | -113.48 | -9.35 | -5.74 | 4.44 | 0.88 | 0.3 |
Change in Accounts Receivable | -12.03 | -12.03 | 13.31 | -2.07 | 0.07 | -4.3 |
Change in Inventory | 11.9 | 11.9 | -16.55 | 1.22 | 16.42 | -2.71 |
Change in Accounts Payable | -7.18 | -7.18 | -5.41 | -8.81 | -14.24 | 24.48 |
Change in Unearned Revenue | -0.99 | -0.99 | 15.21 | 5.85 | -11.26 | 41.5 |
Change in Other Net Operating Assets | -9.23 | -9.23 | -10.47 | 2.08 | 3.67 | -15.47 |
Operating Cash Flow | -132.71 | -26.27 | -13.15 | -12.82 | -6.68 | 35.99 |
Capital Expenditures | -2.64 | -2.56 | -2.47 | -8.8 | -27.6 | -6.12 |
Sale of Property, Plant & Equipment | 3.6 | 2.94 | 0 | - | 0.71 | 0.36 |
Cash Acquisitions | 6.89 | - | - | -10.45 | - | - |
Divestitures | -0.06 | -0.06 | - | 4.07 | - | - |
Investment in Securities | - | - | 1.75 | 1.49 | 24.05 | -10.58 |
Other Investing Activities | -37.57 | -37.57 | 0.25 | 0.76 | -5.67 | -7.07 |
Investing Cash Flow | -29.78 | -37.24 | -0.47 | -12.93 | -8.51 | -26.51 |
Short-Term Debt Issued | - | - | 5.16 | 0.1 | - | - |
Long-Term Debt Issued | - | 147 | 90.99 | 56.12 | 47.6 | 15.8 |
Total Debt Issued | 146.2 | 147 | 96.15 | 56.22 | 47.6 | 15.8 |
Short-Term Debt Repaid | - | - | -0.1 | - | - | - |
Long-Term Debt Repaid | - | -64.05 | -83.32 | -50.05 | -19.5 | -35.99 |
Total Debt Repaid | -70.86 | -64.05 | -83.42 | -50.05 | -19.5 | -35.99 |
Net Debt Issued (Repaid) | 75.34 | 82.95 | 12.73 | 6.17 | 28.1 | -20.19 |
Issuance of Common Stock | 81.19 | - | - | - | - | - |
Financing Cash Flow | 156.53 | 82.95 | 12.73 | 6.17 | 28.1 | -20.19 |
Net Cash Flow | -5.96 | 19.44 | -0.89 | -19.58 | 12.91 | -10.72 |
Free Cash Flow | -135.36 | -28.83 | -15.62 | -21.62 | -34.28 | 29.87 |
Free Cash Flow Margin | -33.81% | -7.48% | -3.92% | -5.36% | -7.20% | 8.09% |
Free Cash Flow Per Share | -0.07 | -0.01 | -0.01 | -0.01 | -0.02 | 0.02 |
Cash Interest Paid | 4.28 | 4.58 | 6.08 | 6.4 | 5.47 | 1.64 |
Cash Income Tax Paid | 0 | 0 | -0.04 | -1.49 | -0.06 | 0.33 |
Levered Free Cash Flow | 22.03 | -48.97 | -4.2 | -13.24 | -25.89 | 53.37 |
Unlevered Free Cash Flow | 24.89 | -46.1 | -0.97 | -9.24 | -22.48 | 54.39 |
Change in Working Capital | -17.53 | -17.53 | -3.91 | -1.73 | -5.33 | 43.51 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.